Literature DB >> 20685340

Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system.

Beatrijs L P Bloemers1, Chantal J M Broers, Louis Bont, Michel E Weijerman, Reinoud J B J Gemke, A Marceline van Furth.   

Abstract

Down syndrome (DS) is the most common chromosomal abnormality among live-born infants. Respiratory tract infections are the most important cause of mortality in individuals with DS at all ages. In recent decades several studies have been performed to elucidate abnormalities of the immune system in DS. However, the influence of the immune system on the occurrence of respiratory tract infections in these children has never been reviewed.
Copyright © 2010 Institut Pasteur. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20685340     DOI: 10.1016/j.micinf.2010.05.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  30 in total

1.  Down syndrome: is it really characterized by precocious immunosenescence?

Authors:  Maaike Aa Kusters; Ruud Hj Verstegen; Esther de Vries
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  Age-related alterations of the CD19 complex and memory B cells in children with Down syndrome.

Authors:  Ayse Nazli Seckin; Hulya Ozdemir; Ayca Ceylan; Hasibe Artac
Journal:  Clin Exp Med       Date:  2017-02-14       Impact factor: 3.984

3.  Increased pro-inflammatory cytokine production in Down Syndrome children upon stimulation with live influenza A virus.

Authors:  Chantal J M Broers; Reinoud J B J Gemke; Michel E Weijerman; Koen F van der Sluijs; A Marceline van Furth
Journal:  J Clin Immunol       Date:  2011-12-15       Impact factor: 8.317

4.  Heart Transplantation in Children With Down Syndrome.

Authors:  Justin Godown; Darlene Fountain; Neha Bansal; Rebecca Ameduri; Susan Anderson; Gary Beasley; Danielle Burstein; Kenneth Knecht; Kimberly Molina; Sherry Pye; Marc Richmond; Joseph A Spinner; Kae Watanabe; Shawn West; Zdenka Reinhardt; Janet Scheel; Simon Urschel; Chet Villa; Seth A Hollander
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

5.  Universal palivizumab prophylaxis for children with Down syndrome in Japan: analysis with interrupted time-series.

Authors:  Masato Takeuchi; Koji Kawakami
Journal:  Hum Vaccin Immunother       Date:  2020-09-22       Impact factor: 3.452

Review 6.  Down syndrome.

Authors:  Stylianos E Antonarakis; Brian G Skotko; Michael S Rafii; Andre Strydom; Sarah E Pape; Diana W Bianchi; Stephanie L Sherman; Roger H Reeves
Journal:  Nat Rev Dis Primers       Date:  2020-02-06       Impact factor: 52.329

7.  Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations.

Authors:  B Paes; I Mitchell; A Li; K L Lanctôt
Journal:  Eur J Pediatr       Date:  2011-12-28       Impact factor: 3.183

Review 8.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

9.  Genome-wide expression analysis in Down syndrome: insight into immunodeficiency.

Authors:  Chong Li; Lei Jin; Yun Bai; Qimin Chen; Lijun Fu; Minjun Yang; Huasheng Xiao; Guoping Zhao; Shengyue Wang
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome.

Authors:  Xu-Qiao Chen; Zhuo Xing; Quang-Di Chen; Richard J Salvi; Xuming Zhang; Benjamin Tycko; William C Mobley; Y Eugene Yu
Journal:  Front Aging Neurosci       Date:  2021-07-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.